The role of N-acetyl Cysteine in the eradication of H.Pylori

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N103

Enrollment

167

Registered

2019-04-08

Start date

2018-03-06

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspepsia. Functional dyspepsia

Interventions

Intervention 1: Intervention group: We treat intervention group 4 drugs (Clarithromycin - Amoxicillin - Omeprazole - Bismuth)(Abidi Co) and N-Acetylcysteine (Ave Sina Co)600 milligram every 12 hours

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 20 years They have not already received the eradication regimen

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding Nausea and vomiting Lack of cooperation

Design outcomes

Primary

Measure	Time frame
Eradication Helicobacter infection. Timepoint: 4 weeks after treatment. Method of measurement: Urease respiratory test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Zahedin Kheiri

Arak University of Medical Sciences

z.kheiri@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026